View Abstract [14] Greco A, Minghetti L, Levi G
However, the clinical evidence included in that review was insufficient to draw conclusive interpretations about GLP-1s potential in individuals with neurodegenerative diseases
Now is a great time to be in the lab and working to test new products that service consumers who are on a GLP-1 diet. If youre interested in watching the webinar, become an FI member to access this and all of The Food Institute s educational content
This can help reduce fatigue, improve cognitive performance, and alleviate muscle soreness
Who Benefits Most from NAD+ Therapy NAD+ IV therapy is particularly beneficial for adults over 35 experiencing fatigue, brain fog, or accelerated aging, high-performance professionals seeking cognitive optimisation, athletes wanting enhanced recovery and endurance, and individuals with chronic fatigue syndrome or fibromyalgia